Adis Journals
Browse
Summary slide.png (116 kB)

Recombinant FVIIIFc Versus BAY 94-9027 For Treatment of Patients with Haemophilia A: Comparative Efficacy Using a Matching Adjusted Indirect Comparison

Download (116 kB)
media
posted on 2021-01-04, 18:15 authored by Zalmai Hakimi, Elena Santagostino, Maarten J. Postma, Jameel Nazir

Article full text


The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).


© The authors, CC-BY-NC 2020.

History

Usage metrics

    Advances in Therapy

    Categories

    Keywords

    Annualised bleeding rateBAY 94-9027Damactocog alfa pegolEfmoroctocog alfaFactor VIII-Fc fusion proteinHaematologyHaemophilia A; rFVIIITreatment outcome

    Licence

    CC BY-NC 4.0

    Exports